IDEXX Cash And Short Term Investments vs Total Liab Analysis

IDXX Stock  USD 506.38  1.28  0.25%   
IDEXX Laboratories financial indicator trend analysis is infinitely more than just investigating IDEXX Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IDEXX Laboratories is a good investment. Please check the relationship between IDEXX Laboratories Cash And Short Term Investments and its Total Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Cash And Short Term Investments vs Total Liab

Cash And Short Term Investments vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IDEXX Laboratories Cash And Short Term Investments account and Total Liab. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between IDEXX Laboratories' Cash And Short Term Investments and Total Liab is 0.41. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Liab in the same time period over historical financial statements of IDEXX Laboratories, assuming nothing else is changed. The correlation between historical values of IDEXX Laboratories' Cash And Short Term Investments and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of IDEXX Laboratories are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Cash And Short Term Investments i.e., IDEXX Laboratories' Cash And Short Term Investments and Total Liab go up and down completely randomly.

Correlation Coefficient

0.41
Relationship DirectionPositive 
Relationship StrengthWeak

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of IDEXX Laboratories balance sheet. This account contains IDEXX Laboratories investments that will expire within one year. These investments include stocks and bonds that can be liquidated by IDEXX Laboratories fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.At this time, IDEXX Laboratories' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 44.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 171.1 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.9B2.0B2.2B2.3B
Total Revenue3.2B3.4B3.7B3.8B

IDEXX Laboratories fundamental ratios Correlations

0.970.750.730.980.330.910.950.630.980.840.480.99-0.320.970.97-0.920.820.960.770.720.630.110.90.60.54
0.970.70.650.990.390.860.970.520.980.880.360.98-0.420.920.95-0.890.850.890.860.70.650.040.880.580.54
0.750.70.190.750.770.520.770.270.690.460.480.72-0.280.760.8-0.650.920.780.730.570.930.730.490.670.67
0.730.650.190.64-0.390.890.590.750.720.730.330.710.050.740.65-0.750.20.690.190.61-0.06-0.390.820.250.14
0.980.990.750.640.420.860.960.520.990.850.360.99-0.390.940.96-0.90.860.90.850.690.680.10.860.620.58
0.330.390.77-0.390.420.00.47-0.290.320.150.10.35-0.520.310.41-0.220.790.310.720.20.910.740.070.470.51
0.910.860.520.890.860.00.840.670.920.850.30.9-0.190.930.9-0.970.550.830.50.760.31-0.110.890.410.33
0.950.970.770.590.960.470.840.40.970.850.30.97-0.430.930.95-0.890.860.870.830.740.690.150.870.580.53
0.630.520.270.750.52-0.290.670.40.520.390.760.550.180.560.52-0.550.270.730.230.360.11-0.140.610.40.32
0.980.980.690.720.990.320.920.970.520.90.310.99-0.370.960.97-0.940.790.890.780.740.590.030.90.550.5
0.840.880.460.730.850.150.850.850.390.90.090.88-0.320.830.82-0.830.590.70.620.680.35-0.190.820.380.33
0.480.360.480.330.360.10.30.30.760.310.090.390.080.390.34-0.230.410.70.310.120.420.30.380.430.39
0.990.980.720.710.990.350.90.970.550.990.880.39-0.380.960.96-0.910.820.920.80.70.620.060.90.570.51
-0.32-0.42-0.280.05-0.39-0.52-0.19-0.430.18-0.37-0.320.08-0.38-0.27-0.320.3-0.5-0.22-0.630.11-0.48-0.02-0.340.130.2
0.970.920.760.740.940.310.930.930.560.960.830.390.96-0.270.97-0.930.770.920.680.780.590.170.870.570.5
0.970.950.80.650.960.410.90.950.520.970.820.340.96-0.320.97-0.960.830.90.760.80.670.210.830.60.55
-0.92-0.89-0.65-0.75-0.9-0.22-0.97-0.89-0.55-0.94-0.83-0.23-0.910.3-0.93-0.96-0.68-0.82-0.62-0.79-0.48-0.06-0.84-0.49-0.42
0.820.850.920.20.860.790.550.860.270.790.590.410.82-0.50.770.83-0.680.80.940.510.950.490.60.650.65
0.960.890.780.690.90.310.830.870.730.890.70.70.92-0.220.920.9-0.820.80.710.640.660.220.840.620.56
0.770.860.730.190.850.720.50.830.230.780.620.310.8-0.630.680.76-0.620.940.710.40.850.230.610.550.55
0.720.70.570.610.690.20.760.740.360.740.680.120.70.110.780.8-0.790.510.640.40.350.150.640.650.63
0.630.650.93-0.060.680.910.310.690.110.590.350.420.62-0.480.590.67-0.480.950.660.850.350.690.370.590.62
0.110.040.73-0.390.10.74-0.110.15-0.140.03-0.190.30.06-0.020.170.21-0.060.490.220.230.150.69-0.180.430.47
0.90.880.490.820.860.070.890.870.610.90.820.380.9-0.340.870.83-0.840.60.840.610.640.37-0.180.380.28
0.60.580.670.250.620.470.410.580.40.550.380.430.570.130.570.6-0.490.650.620.550.650.590.430.380.97
0.540.540.670.140.580.510.330.530.320.50.330.390.510.20.50.55-0.420.650.560.550.630.620.470.280.97
Click cells to compare fundamentals

IDEXX Laboratories Account Relationship Matchups

IDEXX Laboratories fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.8B2.3B2.4B2.7B3.3B3.4B
Other Current Liab322.9M415.6M458.9M433.7M478.7M502.6M
Total Current Liabilities725.3M582.8M763.6M1.2B951.5M999.1M
Total Stockholder Equity177.5M632.1M690.0M608.7M1.5B1.6B
Property Plant And Equipment Net533.8M555.2M587.7M649.5M702.2M737.3M
Net Debt897.3M524.6M779.2M1.2B493.9M255.9M
Retained Earnings1.6B2.2B2.9B3.6B4.4B4.7B
Accounts Payable72.2M74.6M116.1M110.2M110.6M116.2M
Cash90.3M383.9M144.5M112.5M453.9M476.6M
Non Current Assets Total1.2B1.2B1.5B1.6B1.8B1.9B
Non Currrent Assets Other299.0M337.2M397.4M425.6M448.5M470.9M
Cash And Short Term Investments90.3M383.9M144.5M112.5M453.9M476.6M
Net Receivables269.3M331.4M368.3M400.6M457.4M480.3M
Common Stock Shares Outstanding87.5M86.7M86.6M84.6M84.0M94.9M
Liabilities And Stockholders Equity1.8B2.3B2.4B2.7B3.3B3.4B
Inventory195.0M209.9M269.0M367.8M380.3M399.3M
Other Current Assets125.0M137.5M173.8M220.5M203.6M213.8M
Other Stockholder Equity(1.4B)(1.5B)(2.2B)(2.9B)(2.9B)(2.8B)
Total Liab1.7B1.7B1.7B2.1B1.8B1.9B
Total Current Assets679.6M1.1B955.7M1.1B1.5B1.6B
Non Current Liabilities Total929.3M1.1B983.6M902.2M823.8M865.0M
Intangible Assets58.5M52.5M99.0M97.7M84.5M74.5M
Short Long Term Debt Total987.7M908.5M923.7M1.3B947.9M995.3M
Short Term Debt288.8M50.0M148.5M654.0M325.0M208.6M
Property Plant And Equipment Gross614.5M646.3M1.3B649.5M1.6B1.7B
Accumulated Other Comprehensive Income(46.2M)(53.6M)(53.5M)(77.8M)(71.2M)(67.6M)
Common Stock Total Equity10.6M10.6M10.7M10.7M12.3M9.0M
Common Stock10.6M10.6M10.7M10.7M10.8M9.2M
Other Assets240.2M676.7M893.9M387.5M445.6M467.9M
Treasury Stock(2.3B)(2.6B)(2.8B)(3.6B)(3.2B)(3.1B)
Property Plant Equipment533.8M555.2M587.7M649.5M746.9M784.2M
Current Deferred Revenue41.5M42.6M40.0M37.9M37.2M25.0M
Good Will239.7M243.3M359.3M361.8M366.0M206.0M
Other Liab162.8M220.5M208.4M106.6M122.6M83.3M
Long Term Debt698.9M858.5M775.2M694.4M622.9M380.8M
Net Tangible Assets(120.7M)336.2M690.0M149.3M134.3M141.1M
Noncontrolling Interest In Consolidated Entity264K280K352K707K813.1K853.7K
Retained Earnings Total Equity1.6B2.2B2.9B3.6B4.1B4.3B
Long Term Debt Total698.9M858.5M775.2M694.4M798.5M502.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for IDEXX Stock Analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.